HealthEquity (FRA:2HE) LT-Debt-to-Total-Asset: 0.30 (As of Apr. 2026)

What is HealthEquity LT-Debt-to-Total-Asset?

HealthEquity FRA:2HE +0.61% 91 LT-Debt-to-Total-Asset is 0.30 as of Apr. 2026. GuruFocus rates FRA:2HE with a GF Score™ of 91/100 and a GF Value™ of €88.45. The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. HealthEquity's long-term debt to total assests ratio for the quarter that ended in Apr. 2026 was 0.30.

HealthEquity's long-term debt to total assets ratio declined from Apr. 2025 (0.32) to Apr. 2026 (0.30). It may suggest that HealthEquity is progressively becoming less dependent on debt to grow their business.

HealthEquity (FRA:2HE) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

HealthEquity LT-Debt-to-Total-Asset Related Terms

HealthEquity LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for HealthEquity's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthEquity LT-Debt-to-Total-Asset Chart

HealthEquity Annual Data

Trend

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Jan25

Jan26

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.32

0.31

0.29

0.32

0.29

HealthEquity Quarterly Data
	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25	Jan26	Apr26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.32	0.31	0.30	0.29	0.30

91GF Score

HealthEquity Inc FRA:2HE

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

HealthEquity LT-Debt-to-Total-Asset Calculation

HealthEquity's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jan. 2026 is calculated as

LT Debt to Total Assets (A: Jan. 2026 )	=	Long-Term Debt & Capital Lease Obligation (A: Jan. 2026 )	/	Total Assets (A: Jan. 2026 )
	=	843.825	/	2876.663
	=	0.29

HealthEquity's Long-Term Debt to Total Asset Ratio for the quarter that ended in Apr. 2026 is calculated as

LT Debt to Total Assets (Q: Apr. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Apr. 2026 )	/	Total Assets (Q: Apr. 2026 )
	=	833.425	/	2826.789
	=	0.29

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.30 mean?

HealthEquity (FRA:2HE) has a LT-Debt-to-Total-Asset of 0.30 as of Apr. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on HealthEquity and its competitors.

Is HealthEquity's LT-Debt-to-Total-Asset too high?

HealthEquity's current LT-Debt-to-Total-Asset is 0.30. Overall, HealthEquity has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.

How does HealthEquity's LT-Debt-to-Total-Asset compare to HNGE and TEM?

HealthEquity's LT-Debt-to-Total-Asset of 0.30 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Healthcare Providers & Services company?

A good LT-Debt-to-Total-Asset depends on the Healthcare Providers & Services industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on HealthEquity and its competitors. HealthEquity's current LT-Debt-to-Total-Asset is 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is HealthEquity stock overvalued right now?

HealthEquity (FRA:2HE) has a current LT-Debt-to-Total-Asset of 0.30. The stock's GF Value™ is €88.45, compared to a current price of €83.00 — trading 6.2% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.30. HealthEquity's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current LT-Debt-to-Total-Asset is 0.30 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthEquity (FRA:2HE) Overvalued in 2026?

Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued. The current stock price of €83.00 is trading 6.2% below its estimated GF Value™ of €88.45.

Key valuation signals for FRA:2HE:

LT-Debt-to-Total-Asset: 0.30
GF Value™: €88.45 vs. price of €83.00 (6.2% below fair value)
GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HealthEquity Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies HNGE TEM TXG DOCS WAY PRVA HTFL OMCL TDOC SDGR VEEV ASX:PME BTSG TSE:2413 HKSE:02228 NSE:IKS SZSE:300253 NSE:SAGILITY HKSE:01833 SGX:ULG

Other Exchanges HQY:USA

Address 15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020

Website https://www.healthequity.com

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

91GF Score

Get the complete analysis for FRA:2HE

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€83.00

Price

€88.45

GF Value

View FRA:2HE Analysis

See LT-Debt-to-Total-Asset data for all stocks →